Processa Pharmaceuticals, Inc. (PCSA) has 19 SEC Form 4 insider filings on record in the last 90 days. That includes 5 insider purchases totalling $26K. Most recent filing: Aug. 11, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 11, 2026 filed Aug. 8, 2026 | Ng George K Chief Executive Officer | $0 | 3,200 | +9% | No | |
|
|
||||||
| July 30, 2026 filed July 28, 2026 | GUJRATHI SHEILA Director | $0 | 83,123 | 0% | No | |
|
|
||||||
| July 28, 2026 filed July 26, 2026 | Yorke Justin W Director | $0 | 33,500 | 0% | No | |
|
|
||||||
| July 28, 2026 filed July 26, 2026 | SKIBSTED RUSSELL Chief Financial Officer | $0 | 11,883 | 0% | No | |
|
|
||||||
| July 28, 2026 filed July 26, 2026 | Pannu Geraldine Director | $0 | 33,500 | 0% | No | |
|
|
||||||
Showing the 5 most recent of 19 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free